drugset / Trial / NCT06525168
Safety, Tolerability and Pharmacokinetic Characteristics Evaluation on DA414
RandomizedSequentialDouble-blindTreatment
Summary
The purpose of this study is to assess the safety, tolerability, pharmacokinetics (PK) and Food Effects of DA414 Granules in Chinese healthy subjects with single and multiple doses.
Timeline
- Start
- 2024-02-06
- Primary completion
- 2025-09-30
- Completion
- 2026-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DA414 | Unknown | 12.5 mg | Oral |
| Subject | DA414 | Unknown | 25 mg | Oral |
| Subject | DA414 | Unknown | 50 mg | Oral |
| Subject | DA414 | Unknown | 100 mg | Oral |
| Subject | DA414 | Unknown | 200 mg | Oral |